🇮🇱 Bay Ntn 33893 in Israel

Bay Ntn 33893 (imidacloprid) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Bay Ntn 33893 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Israel

Frequently asked questions

Is Bay Ntn 33893 approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Bay Ntn 33893 in Israel?

Marketing authorisation holder not available in our data.